Literature DB >> 16840980

[French adaptation of the Hopkins Verbal Learning Test].

D Rieu1, A-C Bachoud-Lévi, A Laurent, E Jurion, G Dalla Barba.   

Abstract

INTRODUCTION: A number of tests are currently used in clinical and research settings for the assessment of patients with memory deficits. Among them, the Hopkins Verbal Learning Test (HVLT) is particularly appropriate for the longitudinal follow-up of patients with memory disorders because it exists in six parallel forms, and therefore avoids the risk of learning effect at retest. Since a test with these characteristics is not available in French, we decided to adapt a French version of the HVLT.
METHODS: 180 normal subjects participated in the study. Their mean age was 41 years (SD=11), and they had had on average 12 years of schooling (SD=3). The subjects were randomly divided into 6 groups of 30 subjects. One of the six forms of the French version of the HVLT was administered orally to each group of subjects. Each form consisted of a list of 12 words belonging to 3 different semantic categories. For the construction of the French version of the HVLT, we adopted the same procedure as used in the original version of the test taking into account the French lexical and semantic characteristics of the items. In the first part of the test, the list was administered three times to the subjects. Following each administration, subjects were asked for an immediate free recall. Twenty minutes later, used for intercurrent tasks, subjects were asked for a delayed free recall, which was immediately followed by a recognition memory task. In this task, subjects listened to a list of 24 words, 12 belonging to the studied list and 12 were distractors; the subjects were asked to recognize the 12 studied words.
RESULTS: The subjects' performance was equivalent in the six forms of the test, except for the immediate recall of Form 3 (which was excluded from the test). No significant difference emerged in free recall, delayed free recall, and recognition across the five remaining forms of the test.
CONCLUSION: Our study provides a useful tool for the longitudinal evaluation of patients with memory impairment and may become the test of reference in European longitudinal clinical trials. The French adaptation of the HVLT represents only a first step, because it needs to be standardized, in order to provide norms, and validated, in order to provide values of sensitivity and specificity.

Entities:  

Mesh:

Year:  2006        PMID: 16840980     DOI: 10.1016/s0035-3787(06)75069-x

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  10 in total

1.  Personality and Neuropsychological Profiles in Friedreich Ataxia.

Authors:  Sabrina Sayah; Jean-Yves Rotgé; Hélène Francisque; Marcela Gargiulo; Virginie Czernecki; Damian Justo; Khadija Lahlou-Laforet; Valérie Hahn; Massimo Pandolfo; Antoine Pelissolo; Philippe Fossati; Alexandra Durr
Journal:  Cerebellum       Date:  2018-04       Impact factor: 3.847

2.  HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.

Authors:  Georgette D Kanmogne; Callixte T Kuate; Lucette A Cysique; Julius Y Fonsah; Sabine Eta; Roland Doh; Dora M Njamnshi; Emilienne Nchindap; Donald R Franklin; Ronald J Ellis; John A McCutchan; Fidele Binam; Dora Mbanya; Robert K Heaton; Alfred K Njamnshi
Journal:  BMC Neurol       Date:  2010-07-13       Impact factor: 2.474

3.  Striatal degeneration impairs language learning: evidence from Huntington's disease.

Authors:  R De Diego-Balaguer; M Couette; G Dolbeau; A Dürr; K Youssov; A-C Bachoud-Lévi
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

4.  Detecting Memory Impairment in Deaf People: A New Test of Verbal Learning and Memory in British Sign Language.

Authors:  Tanya Denmark; Jane Marshall; Cath Mummery; Penny Roy; Bencie Woll; Joanna Atkinson
Journal:  Arch Clin Neuropsychol       Date:  2016-12-01       Impact factor: 2.813

Review 5.  Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments.

Authors:  Teresa C Castanho; Liliana Amorim; Joseph Zihl; Joana A Palha; Nuno Sousa; Nadine C Santos
Journal:  Front Aging Neurosci       Date:  2014-02-25       Impact factor: 5.750

6.  How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease.

Authors:  Catherine Schramm; Sandrine Katsahian; Katia Youssov; Jean-François Démonet; Pierre Krystkowiak; Frédéric Supiot; Christophe Verny; Laurent Cleret de Langavant; Anne-Catherine Bachoud-Lévi
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

7.  Portable light therapy in the treatment of unipolar non-seasonal major depressive disorder: study protocol for the LUMIDEP randomised controlled trial.

Authors:  Eve Cosker; Marie Moulard; Samuel Schmitt; Karine Angioi-Duprez; Cédric Baumann; Vincent Laprévote; Raymund Schwan; Thomas Schwitzer
Journal:  BMJ Open       Date:  2021-07-09       Impact factor: 2.692

8.  Obsessive compulsive disorder networks: positron emission tomography and neuropsychology provide new insights.

Authors:  Bruno Millet; Thibaut Dondaine; Jean-Michel Reymann; Aurélie Bourguignon; Florian Naudet; Nematollah Jaafari; Dominique Drapier; Valérie Turmel; Habiba Mesbah; Marc Vérin; Florence Le Jeune
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

9.  Study Protocol on Hormonal Mediation of Exercise on Cognition, Stress and Immunity (PRO-HMECSI): Effects of Different Exercise Programmes in Institutionalized Elders.

Authors:  Ana Maria Teixeira; José Pedro Ferreira; Eef Hogervorst; Margarida Ferreira Braga; Stephan Bandelow; Luís Rama; António Figueiredo; Maria João Campos; Guilherme Eustáquio Furtado; Matheus Uba Chupel; Filipa Martins Pedrosa
Journal:  Front Public Health       Date:  2016-06-27

10.  A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease.

Authors:  Wolfram Hinzen; Joana Rosselló; Cati Morey; Estela Camara; Clara Garcia-Gorro; Raymond Salvador; Ruth de Diego-Balaguer
Journal:  Cortex       Date:  2017-08-09       Impact factor: 4.027

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.